About LAVITH PHARMA PRIVATE LIMITED
LAVITH PHARMA PRIVATE LIMITED is a Private Limited Company and was incorporated on Feb 15, 2017 in India. It is registered at Registrar of Companies, ROC Bangalore. Its registered address is NO. 4, 1ST MAIN, PATTANAGERE R R NAGAR, Bangalore, BANGALORE, Karnataka, India, 560098. Its corporate identification number is (CIN) U74999KA2017PTC100532 and its current status is Active. Its industry classification as per MCA is other Business Activities N.E.C.
LAVITH PHARMA PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). LAVITH PHARMA PRIVATE LIMITED's authorised share capital is ₹5L and its paid up capital is ₹5L. The current board of directors of LAVITH PHARMA PRIVATE LIMITED comprises Chaitanya Basavaraj Dhotrad and Gururaj Nithin.
LAVITH PHARMA PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
U74999KA2017PTC100532
Location
Current Status
Active
Entity Type
Private Limited Company
Date Of Incorporation
Feb 15, 2017
Company Age
9 Years 5 Months
Registrar of Companies
ROC - Bangalore
Last AGM Date
Sep 30, 2025
Latest Revenue
0 - ₹10 Cr as on Mar 31, 2025
Authorized Capital
₹5L
Paid Up Capital
₹5L
Contact Details for LAVITH PHARMA PRIVATE LIMITED
- *****@gmail.com
- Registered Address
- NO. 4, 1ST MAIN, PATTANAGERE R R NAGAR, Bangalore, BANGALORE, Karnataka, India, 560098
Principal Business Activity of LAVITH PHARMA PRIVATE LIMITED
The majority of LAVITH PHARMA PRIVATE LIMITED's turnover comes from Trade.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
G | Trade | G1 | Wholesale Trading | rq{ |
Documents of LAVITH PHARMA PRIVATE LIMITEDFY 25 Available15 mins
15 minsFiling Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns | - |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
List of share holders, debenture holders | Annual Returns and Balance Sheet eForms | Nov 13, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Nov 13, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Nov 13, 2025 |
Form MGT-7A | Annual Returns and Balance Sheet eForms | Nov 13, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Nov 13, 2025 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Nov 12, 2025 |
Form AOC-4 | Annual Returns and Balance Sheet eForms | Nov 12, 2025 |
e-Director?s Report | Annual Returns and Balance Sheet eForms | Nov 12, 2025 |
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents) | Annual Returns and Balance Sheet eForms | Nov 12, 2025 |
Form DPT-3 | Other eForm Documents | Jun 30, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available15 mins
Financials of LAVITH PHARMA PRIVATE LIMITEDFY 25 Available15 mins
LAVITH PHARMA PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of LAVITH PHARMA PRIVATE LIMITED has a compounded annual growth rate (CAGR) of -6% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 9761 | 5236 | 9058 | 1840 | 2117 |
Total Sales | 6735 | 9589 | 2321 | 7128 | 2496 |
Total Expenses | 7734 | 3894 | 9946 | 5079 | 2942 |
Operating Expenses | 6262 | 3057 | 4888 | 8196 | 3158 |
Employee Expenses | 7376 | 3591 | 9444 | 7386 | 3679 |
Operating Income (EBIT) | 1316 | 1346 | 9375 | 9246 | 3684 |
Interest Expenses | 7585 | 4081 | 4633 | 6608 | 8742 |
Expenses from other activities | 2899 | 4011 | 6247 | 8704 | 1829 |
EBITDA | 3264 | 7099 | 4904 | 8093 | 9561 |
Taxes | 1498 | 7890 | 3600 | 2781 | 6093 |
Net Profit | 3615 | 6094 | 7016 | 8012 | 3141 |
Balance Sheet | |||||
Assets | 6863 | 4981 | 6364 | 4626 | 3970 |
Accounts Receivables | 3003 | 5994 | 4793 | 3606 | 7554 |
Inventory | 4247 | 5089 | 8775 | 4456 | 7170 |
Liabilities | 3776 | 5291 | 2538 | 9645 | 5689 |
Total Debt | 4533 | 8872 | 8895 | 3807 | 3076 |
Accounts Payable | 2013 | 1369 | 6671 | 2703 | 8362 |
Equities | 2317 | 1675 | 3515 | 7886 | 1657 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 1635 | 3104 | 4734 | 6912 | 5134 |
EBIT Margin | 6103 | 6394 | 3183 | 1973 | 3181 |
Net Profit Margin | 6155 | 1624 | 1286 | 4071 | 2789 |
Return on Assets (ROA) | 8713 | 8273 | 2046 | 8341 | 6912 |
Return on Equity (ROE) | 6230 | 1994 | 9416 | 9240 | 8971 |
Return on Capital Employed | 4311 | 1903 | 9581 | 8306 | 4063 |
Return on Invested Capital | 6051 | 5874 | 6506 | 6823 | 5507 |
Efficiency Ratios | |||||
Asset Turnover | 2936 | 8285 | 7138 | 9692 | 4648 |
Receivables Turnover | 2424 | 1511 | 7264 | 4571 | 7810 |
Days Sales Outstanding | 6380 | 5828 | 8868 | 4281 | 7115 |
Inventory Turnover | 9352 | 6268 | 2767 | 6643 | 9631 |
Days Inventory Outstanding | 3967 | 9139 | 4909 | 5535 | 6143 |
Payables Turnover | 5168 | 9145 | 7206 | 8360 | 1654 |
Days Payables Outstanding | 4547 | 6667 | 1355 | 1465 | 4392 |
Liquidity Ratios | |||||
Current Ratio | 2285 | 4858 | 8667 | 1990 | 8751 |
Quick Ratio | 2242 | 6773 | 8192 | 1123 | 1037 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 4242 | 8516 | 2400 | 5099 | 9559 |
Debt Ratio | 1179 | 5876 | 9169 | 4716 | 5647 |
Interest Coverage Ratio | 8923 | 7181 | 5299 | 2459 | 3431 |
Debt Service Coverage Ratio | 8577 | 9774 | 9093 | 8724 | 7270 |
Net Debt/EBITDA | 6303 | 5975 | 2152 | 8338 | 2103 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 6349 | 5938 | 7372 | 6130 | 2423 |
Earnings Growth Rate (CAGR) | 9154 | 9265 | 2227 | 8281 | 5209 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of LAVITH PHARMA PRIVATE LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | -6% |
3 Year | 441 |
5 Year | 121 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 52% |
3 Year | 527 |
5 Year | 576 |
MSME Payment Delays by LAVITH PHARMA PRIVATE LIMITED
Credit Ratings of LAVITH PHARMA PRIVATE LIMITED
GSTIN Details of LAVITH PHARMA PRIVATE LIMITED
Board of Directors and Signatories of LAVITH PHARMA PRIVATE LIMITED
Board of Directors of LAVITH PHARMA PRIVATE LIMITED
Here is the list of current board of directors of LAVITH PHARMA PRIVATE LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Feb 15, 2017 | 9 Years 5 Months | |
Director | Current | Feb 15, 2017 | 9 Years 5 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of LAVITH PHARMA PRIVATE LIMITED
Here is the list of current signatories of LAVITH PHARMA PRIVATE LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Feb 15, 2017 | 9 Years 5 Months | |
Director | Current | Feb 15, 2017 | 9 Years 5 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving LAVITH PHARMA PRIVATE LIMITED
Trademarks of LAVITH PHARMA PRIVATE LIMITED
Patents of LAVITH PHARMA PRIVATE LIMITED
FAQs about LAVITH PHARMA PRIVATE LIMITED
Explore our recently published Legal Entities
